URGN
Earnings company data as of 8:02 PM ET 10/22
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | 0.38 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by URGN's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $2.9M sold by 1 insider outside a trading plan
- $1.3M sold by 1 insider under 10b5-1 plans
-
Mark Schoenberg Chief Medical OfficerSale$2.9M 60,677 shares at $47.05 51% of stakeTraded Aug 20 Filed Aug 24
-
Mark Schoenberg Chief Medical OfficerPlanned sale$400K 10,000 shares at $40.00 7.7% of stakeTraded Jul 9 Filed Jul 10
-
Mark Schoenberg Chief Medical OfficerPlanned sale$350K 10,000 shares at $35.01 7.2% of stakeTraded Jun 22 Filed Jun 24
-
Mark Schoenberg Chief Medical OfficerPlanned sale$300K 10,000 shares at $30.00 6.9% of stakeTraded May 8 Filed May 11
-
Mark Schoenberg Chief Medical OfficerPlanned sale$250K 10,000 shares at $25.00 6.7% of stakeTraded Nov 19, 2025 Filed Nov 20, 2025
Also filed in the last 12 months, not counted as buying or selling: 17 option exercises and 10 sales to cover taxes.
SEC filings
Recent issuer filings from EDGAR, 16 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 8.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | FORM 10-Q | Filing Doc | |
| 8-K | 3.03,5.02,5.07,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | FORM 10-Q | Filing Doc | |
| DEF 14A | FORM DEF 14A | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 1.01,2.03 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | FORM 10-K | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.